The word sterile on an eye-drop carton answers an important question, but it does not supply every instruction for the period after opening. Container design and the actual label matter. Two preservative-free OTC examples show why a universal opened-bottle rule is unreliable: a single-use Refresh Plus container and a Systane Complete PF multidose bottle have different discard wording.
| Identified label example | Presentation | Stated after-opening instruction |
|---|---|---|
| Refresh Plus, cited Allergan label | Single-use container | Do not reuse; discard once opened |
| Systane Complete PF, cited Alcon label | Multidose bottle | Discard 90days after opening—only for this identified presentation |
Two real labels, different instructions
The Refresh Plus label published on DailyMed identifies single-use containers and says not to reuse them and to discard once opened. The Systane Complete PF multidose label published there states a 90-day discard period after opening. These are examples of the instructions on those identified labels, not permission to apply 90 days to another eye product or to retain a single-use vial.
Both descriptions can include preservative-free wording. That phrase alone therefore does not determine whether a package is single-use or multidose. Check the exact product, presentation and current carton in hand; a similarly named product or another package size may not be the same presentation.
Keep sealed and opened information separate
A printed expiration date, an intact-container requirement and an after-opening discard instruction address different conditions. Do not replace one with another. A personal note about when a multidose bottle was opened can be useful only alongside that bottle's actual instructions and storage conditions; it is not a home test of sterility.
Nor can appearance, smell or an undamaged-looking cap establish that an opened product remains suitable. FDA's eye-drop guidance emphasizes contamination precautions and directs consumers to current warnings and recalls. No comparison here establishes that a particular purchased bottle is unaffected by a recall or has been stored correctly.
The clinical boundary comes first
FDA advises stopping eye-drop use if problems occur, including discharge, pain, vision changes or discomfort, and discussing unexpected effects with a doctor. Do not wait for a personal storage note to be complete before seeking appropriate advice. The two OTC label examples are not a change to a prescribed regimen or a recommendation that either product fits a person's eye condition.
If the carton is missing or the opening date or presentation is unclear, ask a pharmacist or the maker about the exact product rather than import a remembered rule from another brand. The useful answer may be that the information cannot be established, not an improvised shelf life.
The usable distinction
The practical comparison has three parts: what the sealed package states, whether this is a single-use or multidose presentation, and what its own after-opening instructions require. Keep those parts attached to the actual product. The word sterile should not be made to carry information it does not contain.
Sources & further reading
Published sources for the details and examples discussed in this story.
